Biotechnology can either be used to save biodiversity or save it – it is a question of bioethics and regulation.
Gutmann '18 -President of the University of Pennsylvania and Christopher H. Browne Distinguished Professor of Political Science and Professor of Communication [Amy and Jonthan D Moreno, Apr 16, "Keep CRISPR Safe," https://www.foreignaffairs.com/articles/2018-04-16/keep-crispr-safe]
The goal of a gene drive is to spread or suppress certain genes in a wild population of organisms. It works by exploiting a quirk of nature. In sexually reproducing species, most genes have a 50 percent chance of being passed from parent to child, as offspring receive half their genes from each parent. As a result, genetic mutations normally spread only if they make an organism more likely to survive or breed. But some genes have evolved mechanisms that give them better than 50 percent odds of being passed on. That allows changes in those genes to proliferate quickly even if they have no effect on evolutionary fitness. Scientists can exploit this tendency by using CRISPR to insert genetic material into the “selfish” part of an organism’s genome, ensuring that the new trait will be passed on to most offspring, eventually spreading through large populations.
This process could be exploited both to improve public health and to promote economic development. Scientists could use gene drives to break disease transmission chains, eliminating the need to use costly and harmful insecticides. For example, researchers are looking at using the technology to inhibit the transmission of Lyme bacteria from mice to ticks, a move that could wipe out Lyme disease among humans, since humans can catch the disease only from tick bites. In agriculture, gene drives could immunize plants against many kinds of pathogens and curb or eliminate populations of invasive animals, such as mice, that destroy crops. Researchers are working to develop a house mouse that can give birth only to male offspring. If the altered mice were released into the wild, female mice would gradually disappear and the species would die off within the area in which the altered mice were introduced.
Gene drives could also reverse some worrying environmental trends. Many amphibian species, such as frogs, toads, and newts, have suffered catastrophic declines over the last few decades. If scientists introduced engineered genes that rendered amphibians immune to common pathogens, any species could recover.
But alongside these benefits come serious risks. A gene drive gone wrong could leave a species extinct or introduce dramatic and unintended effects. Most gene drives would likely be limited to a single place, such as an island or an isolated and containable area of land, at least at first. If a genetically modified animal or plant escaped, however, then the gene drive could spread uncontrollably. And if a modified organism mated with a member of another species, it could transmit the changes to new populations. Entire species could be wiped out and ecosystems upended.
These risks are dramatic, but they are also far off. In part because the research is at such an early stage, scientists disagree about how much and what kind of regulation and guidance will be required. So governments should follow the principle of regulatory parsimony, which dictates that they should impose only those restrictions necessary to maintain ethical standards and public safety. Doing so will maximize the scope of free scientific discovery in a way that is consistent with serving the public good. In the countries where much of the research is taking place, before imposing new restrictions, governments should rationalize the current system of regulation. In the United States, for example, the Department of Agriculture, the Food and Drug Administration, and the Environmental Protection Agency all share responsibility for different aspects of field trials and commercial products. They should harmonize their biological safety guidelines for gene-drive studies. On the international stage, the Cartagena Protocol on Biosafety, an agreement among most of the world’s countries that came into force in 2003, regulates genetically modified organisms, but the United States has not signed it.
In lieu of formal regulations on gene drives, scientists could agree to build safety measures into gene-drive systems, such as alterations that would cancel out previous drives or gene modifications designed to grow less frequent over time, so that successive generations would express the gene less and less once the original problem has been sufficiently ameliorated. Researchers will also need to be transparent about their work and consult local communities to gain consent before introducing gene drives into the wild.